Neumora Therapeutics, Inc.
Historical 13F Holders
Symbol
NMRA
CUSIP
640979100
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q1
122
65.2 M
$65.2 M
$281 k
2024 Q4
166
80.3 M
$852 M
$117 M
2024 Q3
117
68.6 M
$906 M
$22.4 M
2024 Q2
104
72.7 M
$714 M
$2.54 M
2024 Q1
96
53.1 M
$730 M
$422 k
2023 Q4
68
44.4 M
$756 M
$552 k
2023 Q3
40
44.0 M
$620 M
$0